Nov 6, 2018
STAMFORD, Conn., November 6, 2018 – Purdue Pharma L.P. today announced that the first patient has been enrolled in a ... Read more
Oct 22, 2018
Purdue will support SpineThera’s clinical development program to evaluate sustained-release, injectable treatment options for pain in and near ... Read more
Oct 17, 2018
Long-term efficacy and safety evaluation in patients with insomnia, a sleep-wake disorder, met primary and key secondary efficacy ... Read more
Sep 24, 2018
STAMFORD, Conn. – September 24, 2018 – Marcelo E. Bigal MD, Ph.D. Chief Medical Officer, Purdue Pharma L.P., issued the ... Read more
Sep 6, 2018
Studies Underscore Company’s Ongoing Commitment to Working Collaboratively on Meaningful Solutions to Address the Opioid Crisis STAMFORD, Conn., ... Read more
Sep 6, 2018
Results Show Successful Uptake of Technology and Increased Patient-Provider Communication STAMFORD, Conn., and DANVILLE, Pa. – September 6, ... Read more
Sep 5, 2018
STAMFORD, Conn. and PITTSBURGH, Penn., September 5, 2018 – Purdue Pharma L.P. (Purdue) and Harm Reduction Therapeutics, Inc. today announced ... Read more
Aug 28, 2018
Posters Include Interim Data from Wearable Health Technology Study and Research Initiatives to Evaluate Prescription Drug Monitoring, Take ... Read more
Aug 15, 2018
Purdue Expands Established Commitment to Include a Statewide Education Program in Collaboration with EVERFI and Connecticut Prevention Network ... Read more
Jul 31, 2018
STAMFORD, Conn., July 31, 2018 – Purdue Pharma L.P. today announced completion of a Phase 1b dose-ranging study of a ... Read more
for Healthcare Professionals 
for Patients & Caregivers 
for Payers 
Partnering With Purdue 